Outset Medical Q2 EPS $(0.69) Beats $(0.73) Estimate, Sales $36.00M Beat $35.18M Estimate
Portfolio Pulse from Benzinga Newsdesk
Outset Medical reported Q2 earnings per share (EPS) of $(0.69), beating the analyst consensus estimate of $(0.73) by 5.48%. This is a 10.39% increase over losses from the same period last year. The company also reported quarterly sales of $36.00 million, beating the analyst consensus estimate of $35.18 million by 2.33%. This is a 43.67% increase over sales from the same period last year.
August 04, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Outset Medical's Q2 earnings and sales beat analyst estimates, indicating a positive financial performance.
Outset Medical's better-than-expected Q2 earnings and sales indicate a strong financial performance, which is likely to positively impact investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100